» Articles » PMID: 1961391

Treatment of Neoplastic Spinal Cord Compression: Results of a Prospective Study

Overview
Journal Neurosurgery
Specialty Neurosurgery
Date 1991 Nov 1
PMID 1961391
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Currently, external radiation and steroid therapy are used in most patients with neoplastic spinal cord compression. Surgery is generally used to treat those who do not respond to radiation therapy. To determine the role of de novo surgery in patients with spinal metastases, a prospective study was undertaken. Over a 4 1/2-year period, the cases of 54 patients with radiologically documented spinal metastases were studied. The sites of tumor origin included soft tissue sarcoma (8 patients), kidney (6 patients), lung (5 patients), breast (5 patients), spine (6 patients), unknown primary site (6 patients), and others (18 patients). Sites of compression included the cervical spine segments in 15 patients, thoracic segments in 23, lumbar in 14, and sacral in 2. Before surgery, 24 patients (44%) were nonambulatory. Three surgical approaches were used: anterior vertebral body resection in 45 patients, laminectomy in 7, and lateral osteotomy in 2. After surgery, 37 patients received external radiation therapy. All patients improved (became ambulatory) after surgery, with 23 of 25 patients surviving at 2 years continuing to be ambulatory. The 30-day mortality rate was 6% (three patients); eight patients (15%) sustained various surgical complications. These results are superior to those reported after external radiation therapy and steroids alone, and they support the concept that de novo surgery be considered in selected patients with spinal metastases.

Citing Articles

Impact of perioperative hemoglobin-related parameters on clinical outcomes in patients with spinal metastases: identifying key markers for blood management.

Li Z, Yao W, Wang J, Wang X, Luo S, Zhang P BMC Musculoskelet Disord. 2024; 25(1):632.

PMID: 39118064 PMC: 11311924. DOI: 10.1186/s12891-024-07748-9.


Efficacy and safety of en-bloc resection versus debulking for spinal tumor: a systematic review and meta-analysis.

Zhang K, Zhou Q, Da L, Zhang G World J Surg Oncol. 2024; 22(1):208.

PMID: 39097729 PMC: 11297604. DOI: 10.1186/s12957-024-03494-3.


The Outcome of Molecularly Targeted Therapy after Surgical Treatment of Spinal Metastasis.

Sugita S, Ogiso S, Fujiwara M, Morita E, Koyama T, Hozumi T J Clin Med. 2023; 12(12).

PMID: 37373615 PMC: 10299002. DOI: 10.3390/jcm12123920.


Epidemiology, management, and treatment outcomes of metastatic spinal melanoma.

Zheng D, Soldozy S, Mulligan K, Levoska M, Cohn E, Finberg A World Neurosurg X. 2023; 18:100156.

PMID: 36875322 PMC: 9976572. DOI: 10.1016/j.wnsx.2023.100156.


The predictive ability of routinely collected laboratory markers for surgically treated spinal metastases: a retrospective single institution study.

Li Z, Huang L, Guo B, Zhang P, Wang J, Wang X BMC Cancer. 2022; 22(1):1231.

PMID: 36447178 PMC: 9706860. DOI: 10.1186/s12885-022-10334-8.